Clinical Trials Directory

Trials / Completed

CompletedNCT04528043

Infections and Colonization With the Third Group of Enterobacteriaceae in the Intensive Care Unit

Infections and Colonization With the Third Group of Enterobacteriaceae in the Intensive Care Impact on the Mortality and Morbidity

Status
Completed
Phase
Study type
Observational
Enrollment
179 (actual)
Sponsor
Central Hospital, Nancy, France · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

There is a lack of data whether colonization and infection with Enterobacteriaceae of the third group (EB3) affect the outcomes for ICU patients. This study evaluated the effects of EB3 colonization and infection on ICU mortality, ICU length of stay (LOS) and broad-spectrum antibiotic exposure. We focused on the sub type Enterobacter regarding its a priori higher risk of resistance.

Conditions

Timeline

Start date
2017-04-01
Primary completion
2019-01-10
Completion
2019-12-31
First posted
2020-08-27
Last updated
2020-08-27

Locations

1 site across 1 country: France

Source: ClinicalTrials.gov record NCT04528043. Inclusion in this directory is not an endorsement.